which glp-1 is best for cardiovascular benefit Drugs & What They Do TrimRX | Cardiovascular Risks of

Integrative network analysis highlights biological processes underlying GLP-1 stimulated insulin secretion: a DIRECT study

Stevanato Group can offer in-house expertise in the design and delivery of highly efficient and flexible assembly production lines, which can deliver time and cost savings for pharma partners in various scenarios. For drug owners and manufacturers, the Aidaptus plunger rods ability to automatically self-adjust to the drug fill volume during final assembly, without requiring any part changes or associated process steps, streamlines the final assembly operation

Efficacy of low carbohydrate diet for type 2 diabetes mellitus management: a systematic review and meta-analysis of randomized controlled trials

BMC Nutr

A study published in JAMA in January 2025 which looked at more than 125,000 overweight or obese people found that nearly 47% of those with type 2 diabetes and 65% of those without diabetes stopped taking their prescribed GLP-1s within a year of starting them

The nutrition criteria have been developed in consultation with the British Nutrition Foundation